Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation

Exp Cell Res. 2009 Aug 15;315(14):2442-52. doi: 10.1016/j.yexcr.2009.05.002. Epub 2009 May 8.

Abstract

Tumors metastatic to the bone produce factors that cause massive bone resorption mediated by osteoclasts in the bone microenvironment. Colony stimulating factor (CSF-1) is strictly required for the formation and survival of active osteoclasts, and is frequently produced by tumor cells. Here we hypothesize that the CSF-1 made by tumor cells contributes to bone destruction in osteolytic bone metastases. We show that high level CSF-1 protected osteoclasts from suppressive effects of transforming growth factor beta (TGF-beta). r3T cells, a mouse mammary tumor cell line that forms osteolytic bone metastases, express abundant CSF-1 in vitro as both a secreted and a membrane-spanning cell-surface glycoprotein, and we show that both the secreted and the cell-surface form of CSF-1 made by r3T cells can support osteoclast formation in co-culture experiments in the presence of RankL. Mice with r3T bone metastases have elevated levels of both circulating and bone-associated CSF-1, and the majority of CSF-1 found in bone metastases is associated with the tumor cells. These results support the idea that tumor-cell produced CSF-1 contributes to osteoclast development and survival in bone metastasis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bone Neoplasms / metabolism*
  • Bone Neoplasms / secondary*
  • Bone Resorption / metabolism*
  • Cell Line, Tumor
  • Coculture Techniques
  • Macrophage Colony-Stimulating Factor / blood
  • Macrophage Colony-Stimulating Factor / metabolism*
  • Mice
  • Osteoclasts / metabolism*
  • RANK Ligand / metabolism
  • Transforming Growth Factor beta / metabolism

Substances

  • RANK Ligand
  • Tnfsf11 protein, mouse
  • Transforming Growth Factor beta
  • Macrophage Colony-Stimulating Factor